Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02864693 · ClinicalTrials.gov registry record · NA

Comparative Effectiveness of Microprocessor Controlled and Carbon Fiber Prosthetic Feet in Transtibial Amputees

A NA study of Amputation, sponsored by Ability Prosthetics and Orthotics.

Completed
Registry status
NA
Development phase
30
Enrollment target
3
Study locations

NCT02864693: Completed NA study of Amputation, sponsored by Ability Prosthetics and Orthotics.

NCT02864693 is a NA study of Amputation that has completed, run by Ability Prosthetics and Orthotics. The registered enrollment target is 30 participants, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02864693, a NA study of Amputation, has completed, sponsored by Ability Prosthetics and Orthotics.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this research is to evaluate benefits of a microprocessor controlled prosthetic ankle-foot device compared to a non-microprocessor controlled or passive carbon fiber prosthetic ankle-foot device.

Primary Outcome

The AMPPRO is a functional test consisting of 21 tasks that are similar to everyday function to test balance, strength and walking ability

Conditions Studied

Amputation

Interventions

  • DEVICE Kinnex
  • DEVICE Pacifica LP

Study Locations (3)

Maryland

  • Ability Prosthetics and Orthotics, Inc. - Hagerstown, MD - Hagerstown

North Carolina

  • Ability Prosthetics and Orthotics, Inc. - Charlotte, NC - Charlotte

Pennsylvania

  • Ability Prosthetics and Orthotics, Inc. - York, PA - York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2016-06
Est. Completion 2018-04
Phase NA
Ability Prosthetics and Orthotics

1 total trials

What the finished NCT02864693 record still lists

NCT02864693 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Amputation appearing as the primary indexed condition, and to 2 interventions - of which Kinnex is the first listed.

NCT02864693 reports a single indexed study location in Maryland, North Carolina, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02864693 about?

NCT02864693 is a clinical study titled "Comparative Effectiveness of Microprocessor Controlled and Carbon Fiber Prosthetic Feet in Transtibial Amputees". The purpose of this research is to evaluate benefits of a microprocessor controlled prosthetic ankle-foot device compared to a non-microprocessor controlled or passive carbon fiber prosthetic ankle-foot device.

What is the current status of trial NCT02864693?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-06. Estimated completion is 2018-04.

What conditions does trial NCT02864693 study?

This clinical trial studies the following conditions: Amputation.

What interventions are being tested in trial NCT02864693?

The interventions under investigation include: Kinnex (DEVICE), Pacifica LP (DEVICE).

Who is sponsoring clinical trial NCT02864693?

This trial is sponsored by Ability Prosthetics and Orthotics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02864693 being conducted?

This trial has 3 study locations across Maryland, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02864693's enrollment target sits among peer trials

30 29th of 65 higher than 37 of 65 other Amputation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02864693, the US trial registry maintained by the National Library of Medicine. NCT02864693 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.